Politics
Trump rejects 'Medicare for All,' promoting drug pricing agreements over single-payer plans
President Donald Trump argued single-payer healthcare is overly expensive, while nonpartisan projections warn current policy shifts could expand the uninsured population.
The short version
- President Donald Trump criticized 'Medicare for All' proposals, asserting that single-payer healthcare would lead to higher taxes and excessive costs.
- Trump claimed his strategy of negotiating confidential drug pricing deals with pharmaceutical companies offers a less expensive and more effective alternative.
- Congressional Budget Office projections indicate recent legislative changes to Medicaid and expiring Affordable Care Act subsidies could increase the number of uninsured Americans by 10 million over ten years.
Key facts
- President Donald Trump stated that government-run universal health insurance would cost too much money and force tax increases.[PBS NewsHour]
- Trump argued that negotiating confidential drug pricing deals with pharmaceutical firms is superior to Democratic proposals for universal coverage.[PBS NewsHour]
- Congressional Budget Office estimates project that Medicaid changes enacted last year could leave 10 million more people uninsured over the next decade.[PBS NewsHour]
- The upcoming expiration of subsidies for Affordable Care Act coverage threatens to raise insurance costs and lower coverage rates.[PBS NewsHour]
What remains uncertain
- The long-term impact of confidential pharmaceutical pricing deals on overall consumer healthcare expenses remains unclear.[PBS NewsHour]
Sources
- WATCH: Trump says 'Medicare for All' doesn't workPBS NewsHour - Politics